e-learning
resources
Munich 2014
Sunday, 07.09.2014
Markers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease
D. J. Dash, S. K. Chhabra, M. Gupta, S. Ramaswamy, V. Bansal, K. K. Deepak (Delhi, New Delhi, India)
Source:
International Congress 2014 – Markers
Session:
Markers
Session type:
Thematic Poster Session
Number:
569
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
D. J. Dash, S. K. Chhabra, M. Gupta, S. Ramaswamy, V. Bansal, K. K. Deepak (Delhi, New Delhi, India). Increased heart rate modulation, sympathetic dominance and systemic inflammation in chronic obstructive pulmonary disease. Eur Respir J 2014; 44: Suppl. 58, 569
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
The systemic inflammation and factors of coagulation in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014
Prediction of chronic renal failure in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Comparison of blood eosinophils and plasma periostin in stable and non-stable chronic obstructive pulmonary disease: How we can improve the management of our patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD
Year: 2016
Systemic inflammation and cardiovascular disease in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Comparison of the effects of smoking and biomass exposure in chronic obstructive pulmonary disease
Source: International Congress 2016 – Smoking-related diseases
Year: 2016
Detection of chronic obstructive pulmonary disease (COPD) in patients with cardio-vascular system pathology
Source: Annual Congress 2013 –COPD treatment and others
Year: 2013
The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Local and systemic inflammation in chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Biomarkers in asthma and COPD
Year: 2013
Different chronic obstructive pulmonary disease phenotypes, systemic inflammation and the risk of falls
Source: International Congress 2016 – Exploring mechanisms in health and disease
Year: 2016
Influence of systemic inflammation and hypoxaemia on bone metabolism in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Peculiarities of intracardiac hemodynamics in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Clinical presentations
Year: 2014
Clinical Impact of Gensini score in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016
Factors associated with exacerbation in a general practitioners’-based Swiss chronic obstructive pulmonary disease (COPD) cohort
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Vascular endothelial dysfunction in chronic obstructive pulmonary disease: Comparison with bronchial asthma, and controls
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Nonlinear dynamics of heart rate variability in patients with chronic obstructive pulmonary disease and changes after 4-week rehabilitation
Source: International Congress 2014 – Clinical physiology and respiratory muscles
Year: 2014
The serum level of surfactantproteind in patients with chronic obstructive pulmonary disease, depending on the nutrtional status
Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD
Year: 2015
Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016
Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept